Stock screenerAll disclosures →
EDGAR →
GPCR
Conviction 57HealthcareScan · Mon, Aug 10, 2026GPCR$53.86+1.35%
ResistanceSupportVol 14Insider sell2
2
Vol MA14 497.56K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price53.86
Change+1.35%
Gap-0.30%
Rel volume0.39×
Avg volume524.59K
Avg $ vol25.89M
SMA 2049.55
SMA 5047.54
SMA 20052.64
Price vs 50+13.29%
Price vs 200+2.31%
MA stackmixed
50/200 cross—
Supertrenddown · 55.36
RSI (14)63
MACD hist0.37
MACD crossbull · 2d
Stoch %K / %D89 / 89
ADX (14)20
+DI / −DI26 / 13
RSI divergence—
MACD divergence—
ATR %+4.82%
ADR %5.28%
52w high93.79
52w low16.31
From 52w high-42.57%
Above 52w low+230.23%
New 52w highNo
SqueezeOff
Bollinger width15.91%
%B1.05
Donchian pos90.60%
Donchian high54.80
Donchian low44.80
AVWAP (52w high)60.00
vs AVWAP high-10.24%
AVWAP (52w low)49.06
vs AVWAP low+9.78%
OBV trendFlat
Chaikin MF (20)0.01
Today vs 20d0.39×
Avg vol (14d)497.56K
Avg vol (20d)524.59K
Avg $ vol (20d)25.89M
Market cap11.52B
RS 3m (vs SPY)+30.04%
RS 6m (vs SPY)-41.53%
RS line new highNo
Trend template5/8
Technical rank49.1
1 week+11.37%
1 month+0.94%
3 months+37.75%
6 months-28.11%
1 year+232.47%
YTD-20.93%
P/E-81.60
P/B8.51
P/S—
P/FCF-51.03
EPS-0.8000
Div yield—
ROE-10.43%
ROA-9.91%
Debt/Eq—
Current20.75
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-15.24%
Price target109.33
Target upside102.99%
Analyst ratingBuy
Institutional31.87%
Ent. value11.25B
Revenue—
Net income-106.16M
Gross profit—
Free cash flow-225.81M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out71.07M
Employees233
ListedFri, Feb 3, 2023
Free float15.5M
Float %7.2%
Short interest6.21M
Days to cover8.8d
Short volume76.5%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.49 vs −$0.39
Last surprise-25.6% miss
Setup gradeC
Conviction57 / 100
Pattern quality—
Tech rank49.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance56.04
Support42.85
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GPCR
No recent disclosed trades by Congress in GPCR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in GPCR · 5 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Berrios John Joseph Chief Commercial Officer · Ordinary Shares · 2026-08-06 | Grant | 140.77K | — | 2026-08-06 | 2026-08-07 |
Berrios John Joseph Chief Commercial Officer · Share option (right to buy) · 2026-08-06 | Grant | 174.61K | — | 2026-08-06 | 2026-08-07 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · Ordinary Shares · 2026-08-04 | Exercise | 11.82K | $4K | 2026-08-04 | 2026-08-05 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · Ordinary Shares · 2026-08-04 | Convert | 11.82K | — | 2026-08-04 | 2026-08-05 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · Share Option (right to buy) · 2026-08-04 | Exercise | 11.82K | — | 2026-08-04 | 2026-08-05 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · American Depositary Shares · 2026-08-04 | Convert | 3.94K | — | 2026-08-04 | 2026-08-05 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · American Depositary Shares · 2026-08-04 | Sell | 3.1K | $153K | 2026-08-04 | 2026-08-05 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · American Depositary Shares · 2026-08-04 | Sell | 839 | $42K | 2026-08-04 | 2026-08-05 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · Ordinary Shares · 2026-07-14 | Exercise | 23.63K | $8K | 2026-07-14 | 2026-07-15 |
Lin Xichen CHIEF SCIENTIFIC OFFICER · Ordinary Shares · 2026-07-14 | Convert | 23.63K | — | 2026-07-14 | 2026-07-15 |
SEC filings
EDGAR filings in GPCR · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.